Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Schrodinger Inc (NQ: SDGR )

26.33 +1.22 (+4.86%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 555,252
Open 25.43
Bid (Size) 26.33 (1)
Ask (Size) 27.50 (1)
Prev. Close 25.11
Today's Range 25.27 - 26.85
52wk Range 15.85 - 36.33
Shares Outstanding 62,027,061
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Tech Stocks to Buy for the Fourth Industrial Revolution
These companies all utilize multiple technologies that are part of the Fourth Industrial Revolution, making them great tech stocks to buy. 
Via InvestorPlace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire

Performance

YTD
+43.80%
+43.80%
1 Month
+8.04%
+8.04%
3 Month
+43.80%
+43.80%
6 Month
+4.57%
+4.57%
1 Year
-26.02%
-26.02%

More News

Read More
Evogene Offers An Excellent Risk/Reward Ratio
Via Talk Markets
Not Quite a Bailout: So Much Banking News to Discuss
Via The Motley Fool
Analyst Expectations for Schrodinger's Future
Via Benzinga
Why Shares of Schrödinger Were Up Today
Via The Motley Fool
Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know
Via Benzinga
4 Analysts Have This to Say About Schrodinger
Via Benzinga
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
Via InvestorPlace
MarketBeat Week in Review – 3/6 - 3/10
Via MarketBeat
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy Interest Rates
3 Amazing AI Stocks for Your March Buy List
Via InvestorPlace
Schrodinger is an AI-Powered Drug Discovery Developer to Watch
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results
From Schrödinger, Inc.
Via Business Wire
3 AI Stocks to Buy for the Future of Automation
Via InvestorPlace
Earnings Scheduled For February 28, 2023
Via Benzinga
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda
From Schrödinger Inc.
Via Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28
From Schrödinger
Via Business Wire
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
Via Talk Markets
Schrödinger to Present at SVB Securities Global Biopharma Conference
From Schrödinger
Via Business Wire
Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million
Via Talk Markets
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.